Rivogenlecleucel + rimiducid for cytopenia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Oct 2017: Trial registered, NCT03301168

The trials

NCT03301168: Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

State
Under way
Phase
Phase 1 and Phase 2
People
120 planned
Started
Apr 2014
Primary completion
11 May 2021
Arms
BPX-501 T cells and Rimiducid
Results
None posted
  1. 4 Oct 2017: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.